Please or to access all these features

AIBU?

Share your dilemmas and get honest opinions from other Mumsnetters.

Immunocompromised people should receive treatment that would prevent them from being infected with COVID-19.

119 replies

dianthus101 · 02/08/2022 11:34

Many people including cancer patients, people on immunosuppressive medications, transplant recipients, people with primary and secondary remain extremely vulnerable to Covid, even after vaccination. For them lockdown has not ended and if anything, it is even worse than 2020 as COVID-19 infections are very high in the community. Some immunosuppressed people have barely been outside since 2020 and the psychological distress is enormous.

I'm not sure if people realise but an antibody treatment (Evusheld) that would prevent them from being infected was authorised by the UK regulator authority (MHRA) in March this year. Despite the fact that the evidence for this treatment is greater than it was for the COVID-19 vaccines (when they were rolled out) it is still not available in the UK (privately or via the NHs) even though it is available in 32 other countries including the US and many European countries. This is because the UK government have not bought any. There doesn't seem to be much publicity about it and I know many immunocompromised people feel very forgotten.

bloodcancer.org.uk/news/leading-charities-and-clinicians-urge-government-to-secure-evusheld/

OP posts:
Glittertwins · 03/08/2022 16:46

@dianthus101 - it's worrying that so many are being denied the treatment within the window. The NHS line she was instructed to call when she tested positive didn't call back as they were meant to - they cleared off home early because it was a Saturday. Now isn't it inconvenient for seriously compromised people to get I'll outside working hours,

RoseAndRose · 03/08/2022 16:39

Also the trials were done on unvaccinated people and there is suspicion about the (lack of) impact on vaccinated people, especially if immunocompromised

You miss the point.

People who do not form as immune response to vaccine are essentially the same as the unvaccinated. This is the absolute closest group for testing the effectiveness.

I mean to say "They did say that vaccines were not going work for severely immcompromised people a few months ago though! That's why evusheld and other monoclonal antibodies were developed in the first place

That vaccination might not work in the severely immune compromised didn't really need saying, because it's the basis fact for all vaccination. It was definitely known and briefed to those affected. It's also a reason why they are the majority of the group which is offered pre-symptomatic advanced covid treatments following a positive test.

No medication is approved for funding on such basic calculations. Thankfully

*Ummm... yes it is! Cost of treating patients without the new drug is very much part of the assessments.

And yes, it is effective against omicron (University of Washington - more effective against 1&2 than 4&5 but still works)

dianthus101 · 03/08/2022 16:32

Glittertwins · 03/08/2022 16:24

My mum has written to her MP about the lack of funding for Evusheld and the MP couldn't give a damn - the reply was like a work experience junior had written it.
The charity that supports her and others with immune deficiencies has tried and tried to keep it in the public eye.
And if you are compromised and get Covid, don't bank on getting the antiviral treatment. She was only just given it in the treatment window as nobody would sanction the treatment despite her following all the guidelines.

I think that's the concern. It's all very well for the government to argue that there are covid treatments available and that pre exposure prophylaxis is therefore not important but there are lots of reports of people not getting treatment within the five day deadline.

OP posts:
Glittertwins · 03/08/2022 16:24

My mum has written to her MP about the lack of funding for Evusheld and the MP couldn't give a damn - the reply was like a work experience junior had written it.
The charity that supports her and others with immune deficiencies has tried and tried to keep it in the public eye.
And if you are compromised and get Covid, don't bank on getting the antiviral treatment. She was only just given it in the treatment window as nobody would sanction the treatment despite her following all the guidelines.

Oblomov22 · 03/08/2022 15:40

£800 doesn't seem that much. Saying that my GP practice complained how expensive my diabetic prescription stuff is!

Sugarplumfairy65 · 03/08/2022 15:38

IneffableGenderFairy · 02/08/2022 19:53

33% disagree? Wow.

Why?

Actually, scratch that. I think it would upset me.

Be cause our lives don't matter.
The new variants don't seem to make the general population ill, just those with certain pre existing life limiting conditions so its not a big deal if the half a million of us in this group die, in fact it will save the nhs money in the long term because they wont have the treat us.

Sugarplumfairy65 · 03/08/2022 15:29

hamstersarse · 03/08/2022 14:13

There is also plenty of evidence now that severely immunocompromised people are not mounting a good immune response to vaccination.

A good example of why long-term data and thorough evidence is required.

No one would have dared say the vaccines don’t work just a few months ago

I was told before I had my first vaccine in january 2021 that it was unlikely to work

Sugarplumfairy65 · 03/08/2022 15:27

SuperPets · 02/08/2022 12:31

The vaccines are neither ineffective or unnecessary, and that comment shows your angle.

All 5 vaccines that ive had have been ineffective. I don't have any antibodies at all and am still having to shield. I'm severely immune compromised .

32 other countries are giving it to their citizens with my condition

Cornettoninja · 03/08/2022 15:26

No one would have dared say the vaccines don’t work just a few months ago

… For specific groups. And it’s been said repeatedly since they’ve been available and certainly since the emergence of Omicron.

dianthus101 · 03/08/2022 14:58

hamstersarse · 03/08/2022 14:13

There is also plenty of evidence now that severely immunocompromised people are not mounting a good immune response to vaccination.

A good example of why long-term data and thorough evidence is required.

No one would have dared say the vaccines don’t work just a few months ago

I mean to say "They did say that vaccines were not going work for severely immcompromised people a few months ago though! That's why evusheld and other monoclonal antibodies were developed in the first place.

OP posts:
dianthus101 · 03/08/2022 14:49

hamstersarse · 03/08/2022 14:13

There is also plenty of evidence now that severely immunocompromised people are not mounting a good immune response to vaccination.

A good example of why long-term data and thorough evidence is required.

No one would have dared say the vaccines don’t work just a few months ago

They did say that vaccines were not going for severely immcompromised people a few months ago though! That's why evusheld and other monoclonal antibodies were developed in the first place.

OP posts:
hamstersarse · 03/08/2022 14:13

There is also plenty of evidence now that severely immunocompromised people are not mounting a good immune response to vaccination.

A good example of why long-term data and thorough evidence is required.

No one would have dared say the vaccines don’t work just a few months ago

dianthus101 · 03/08/2022 12:05

hamstersarse · 03/08/2022 11:42

I believe this is the issue.

There isn't sufficient evidence it works on Omicron which make up 98% of cases.

Also the trials were done on unvaccinated people and there is suspicion about the (lack of) impact on vaccinated people, especially if immunocompromised.

Several studies have shown that is effective against omicron actually. The UK hasn't got some superior knowledge over the 40 countries that are now using it. There is also plenty of evidence now that severely immunocompromised people are not mounting a good immune response to vaccination.

OP posts:
dianthus101 · 03/08/2022 11:50

ChairOfInvisibleStudies · 03/08/2022 11:35

Because it's the first example of NICE undertaking an assessment of covid medications under normal procedures, rather than rapid reviews. I'm using it to highlight that the timelines even for covid drugs are back to being many months or, likely, over a year. Also, the process for an STA is not that much shorter than an MTA - the aim is 49 weeks for an STA and 60 for an MTA, although the reality is often longer.

You are clearly not interested in any comments that aren't wholehearted agreement, even from people knowledgeable in the field, so I think I'm going to bow out now. The points I am trying to make are that due process ought to be followed and that MHRA approval is necessary but not sufficient for drug access through most routes. It's a nuanced area and not as simple as 'this drug works therefore people should have it', as many people on the thread understandably seem to believe.

If you want to pick an example at least pick something similar. Single drug assessments don't normally take a year at all, particularly in this kind of situation.

You are completely incorrect that MHRA approval is not enough for a drug to be prescribed privately. The problem is that it is just not available in the UK. This does not occur with other drugs regardless or whether NICE have given their approval.

Your comments about me not being interested in the opinions of people “knowledgeable in the field” is a bit laughable and patronising. What makes you think I have "no knowledge in the field" and should bow to your superior wisdom? Given some of your ignorant comments I think I probably have more than you.

OP posts:
hamstersarse · 03/08/2022 11:42

ChairOfInvisibleStudies · 03/08/2022 10:43

It literally says on the website you linked that the DHSC have asked to see additional evidence on the efficacy against omicron before deciding whether to buy evushield.

I believe this is the issue.

There isn't sufficient evidence it works on Omicron which make up 98% of cases.

Also the trials were done on unvaccinated people and there is suspicion about the (lack of) impact on vaccinated people, especially if immunocompromised.

ChairOfInvisibleStudies · 03/08/2022 11:35

dianthus101 · 03/08/2022 11:22

Why are you talking about MTAs (multiple drug assessment)?. It is a single drug and the assessment will be much easier and (hopefully) quicker.

Because it's the first example of NICE undertaking an assessment of covid medications under normal procedures, rather than rapid reviews. I'm using it to highlight that the timelines even for covid drugs are back to being many months or, likely, over a year. Also, the process for an STA is not that much shorter than an MTA - the aim is 49 weeks for an STA and 60 for an MTA, although the reality is often longer.

You are clearly not interested in any comments that aren't wholehearted agreement, even from people knowledgeable in the field, so I think I'm going to bow out now. The points I am trying to make are that due process ought to be followed and that MHRA approval is necessary but not sufficient for drug access through most routes. It's a nuanced area and not as simple as 'this drug works therefore people should have it', as many people on the thread understandably seem to believe.

Cornettoninja · 03/08/2022 11:22

Hont1986 · 02/08/2022 17:06

Thank you, that's a helpful post. I'm not against it, I just want to understand the cost and the benefit because the information is pretty light in OP's link.

So the cost of the rollout for Evusheld for those 500,000 people at £800 per dose would be £400 million? And could potentially save in the region of 1000 deaths per year from that clinically vulnerable group?

You’re using two different measures to make a comparison.

Death isn’t the only metric to consider in cost; secondary and primary care costs in treatments during and following an infection, including worsening of existing conditions and death. Given the state of our healthcare services there’s also value of easing pressure overall.

Cost should be no more than £800

That's roughly the equivalent of 2 nights in hospital (not including the actual treatments the patient receives for whatever lands then in there)

No medication is approved for funding on such basic calculations. Thankfully.

dianthus101 · 03/08/2022 11:22

ChairOfInvisibleStudies · 03/08/2022 11:13

In principle, yes. In reality - the MTA I linked to above IS being done fast, for an MTA. They're generally much slower 😬

Why are you talking about MTAs (multiple drug assessment)?. It is a single drug and the assessment will be much easier and (hopefully) quicker.

OP posts:
ChairOfInvisibleStudies · 03/08/2022 11:13

In principle, yes. In reality - the MTA I linked to above IS being done fast, for an MTA. They're generally much slower 😬

dianthus101 · 03/08/2022 11:07

ChairOfInvisibleStudies · 03/08/2022 11:02

Yes, because they were assessed under the rapid programme. That route is now being phased out, so new things coming through will have to go through the normal process

The "normal process" is also faster where necessary. www.nice.org.uk/about/who-we-are/corporate-publications/the-nice-strategy-2021-to-2026

OP posts:
ChairOfInvisibleStudies · 03/08/2022 11:02

Yes, because they were assessed under the rapid programme. That route is now being phased out, so new things coming through will have to go through the normal process

dianthus101 · 03/08/2022 10:57

ChairOfInvisibleStudies · 03/08/2022 10:54

For a while NICE were prepared to issue provisional rapid guidance on covid technologies. That is now changing - see the upcoming MTA for covid antivirals, for example - that consultation began in January and the first committee meeting isn't expected until October www.nice.org.uk/guidance/indevelopment/gid-ta10936

The antivirals are already being used though so not much urgency required.

OP posts:
ChairOfInvisibleStudies · 03/08/2022 10:54

dianthus101 · 03/08/2022 10:47

So you think it just a coincidence that the decision was made the day after clinicians representing 17 different clinical specialities, released a clinical consensus statement saying that there is sufficient evidence that the Covid-19 preventative Evusheld would have clinical benefit to people who are immunocompromised, and a protective antibody treatment program should be delivered as soon as possible? 🙄

NICE actually move quite quickly nowadays, particularly in regards to anything to do with COVID-19 and no doubt there would have been a decision on whether this should be funded by now if they had been asked to give it in March.

For a while NICE were prepared to issue provisional rapid guidance on covid technologies. That is now changing - see the upcoming MTA for covid antivirals, for example - that consultation began in January and the first committee meeting isn't expected until October www.nice.org.uk/guidance/indevelopment/gid-ta10936

dianthus101 · 03/08/2022 10:49

ChairOfInvisibleStudies · 03/08/2022 10:43

It literally says on the website you linked that the DHSC have asked to see additional evidence on the efficacy against omicron before deciding whether to buy evushield.

Before deciding whether the NHS should buy it. They don't make decisions on whether drugs should be prescribed privately.

OP posts:
ChairOfInvisibleStudies · 03/08/2022 10:49

It does sound like the health sec its talking crap (surprised?) - HIV PrEP would be a prime example.